JP2008080027A - Liquid chemical including tissue paper - Google Patents
Liquid chemical including tissue paper Download PDFInfo
- Publication number
- JP2008080027A JP2008080027A JP2006266135A JP2006266135A JP2008080027A JP 2008080027 A JP2008080027 A JP 2008080027A JP 2006266135 A JP2006266135 A JP 2006266135A JP 2006266135 A JP2006266135 A JP 2006266135A JP 2008080027 A JP2008080027 A JP 2008080027A
- Authority
- JP
- Japan
- Prior art keywords
- paper
- talc
- component
- weight
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title description 17
- 239000007788 liquid Substances 0.000 title 1
- 239000000454 talc Substances 0.000 claims abstract description 33
- 229910052623 talc Inorganic materials 0.000 claims abstract description 33
- 239000002245 particle Substances 0.000 claims abstract description 21
- 238000009826 distribution Methods 0.000 claims abstract description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 230000000638 stimulation Effects 0.000 abstract description 2
- 239000004902 Softening Agent Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- -1 aliphatic alcohols Chemical class 0.000 description 20
- 239000000843 powder Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 13
- 239000000284 extract Substances 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- 206010016322 Feeling abnormal Diseases 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000007794 irritation Effects 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000013054 paper strength agent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000008155 medical solution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000013055 pulp slurry Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229940012831 stearyl alcohol Drugs 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000003254 anti-foaming effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- PHDVPEOLXYBNJY-KTKRTIGZSA-N 2-(2-hydroxyethoxy)ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCO PHDVPEOLXYBNJY-KTKRTIGZSA-N 0.000 description 1
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 1
- HOBGCONPBCCQHM-UHFFFAOYSA-N 2-(methylamino)ethane-1,1-diol Chemical class CNCC(O)O HOBGCONPBCCQHM-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- KDISZLKGVIELJB-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].C(C)C[N+](C)(C)CCCCCCCCCCCCCCCCCCCCCC.C(C)C[N+](CCCCCCCCCCCCCCCCCCCCCC)(C)C Chemical compound S(=O)(=O)([O-])[O-].C(C)C[N+](C)(C)CCCCCCCCCCCCCCCCCCCCCC.C(C)C[N+](CCCCCCCCCCCCCCCCCCCCCC)(C)C KDISZLKGVIELJB-UHFFFAOYSA-L 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- HGPXWXLYXNVULB-UHFFFAOYSA-M lithium stearate Chemical compound [Li+].CCCCCCCCCCCCCCCCCC([O-])=O HGPXWXLYXNVULB-UHFFFAOYSA-M 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- DIORMHZUUKOISG-UHFFFAOYSA-N sulfoformic acid Chemical compound OC(=O)S(O)(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- QMGAJHYFGBHHRR-UHFFFAOYSA-M trimethyl(3-octadecoxypropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCOCCC[N+](C)(C)C QMGAJHYFGBHHRR-UHFFFAOYSA-M 0.000 description 1
- HVLUSYMLLVVXGI-USGGBSEESA-M trimethyl-[(z)-octadec-9-enyl]azanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)C HVLUSYMLLVVXGI-USGGBSEESA-M 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Landscapes
- Sanitary Thin Papers (AREA)
Abstract
Description
本発明は、タルク及び保湿成分を含む薬液を含有する薄葉紙に関するものである。 The present invention relates to a thin paper containing a chemical solution containing talc and a moisturizing component.
近時、保湿剤等の薬液を含有させることによりしっとり感を高め、肌触りを向上させた、いわゆる高級タイプのティシューペーパーが市販され、繰り返し鼻をかんでも肌がヒリヒリし難い、または鼻が赤くなり難いとして人気を呼んでいる(例えば、特許文献1、特許文献2参照)。このティシューは柔らかく、滑らかなことから鼻かみだけでなく、化粧用途や乳幼児の口拭き用途などに使われている。しかし、例えば敏感肌の人や乳幼児のいる家庭などで、これらの用途で使う場合、より肌への刺激が少ないものが望まれている。また触感としても化粧用シートのようにさらさらしたものや、肌にフィットする滑らかなものが求められている。
このような薬液含有薄葉紙において、皮脂や水分の拭き取り性を高め、かつさらさらした感触を向上させるために、薬液中にパウダーを含有させることが提案されている(特許文献3参照)。パウダーを含有させることで肌表面の摩擦を減らし、粉体による滑らか感と保湿成分によるしなやか感、しっとり感とが複合し、製品にさらさらとして滑らかな触感を与えることができる。
しかし、従来の薬液含有薄葉紙では、未だ柔らか感および滑らか感を両立できないという問題点があり、また十分な低刺激性が得られていないという問題点があった。
また、特許文献3のものは、粉体の離脱防止のために、接着成分としてCMC、ウレタン樹脂またはラテックスを使用するものであるが、本発明の知見によれば接着成分が、滑らか感を低下させる傾向にあり、かつ柔軟性を阻害することが知見された。
In such medicinal solution-containing thin paper, it has been proposed to contain powder in the medicinal solution in order to improve the wiping property of sebum and moisture and to improve the dry feel (see Patent Document 3). By containing the powder, the friction on the skin surface is reduced, and the smooth feeling of the powder, the supple feeling and moist feeling of the moisturizing component are combined, and the product can be given a smooth and smooth feel.
However, the conventional medicinal solution-containing thin paper has a problem that the soft feeling and the smooth feeling cannot be achieved at the same time, and a sufficient hypoallergenicity has not been obtained.
In addition, Patent Document 3 uses CMC, urethane resin or latex as an adhesive component to prevent the powder from coming off, but according to the knowledge of the present invention, the adhesive component reduces the smoothness. It has been found that it has a tendency to reduce the flexibility.
そこで、本発明の主たる課題は、柔らか感および滑らか感を両立した、より肌への刺激が少ない薬液含有薄葉紙を提供することにある。 Then, the main subject of this invention is providing the chemical | medical solution containing thin paper with less irritation | stimulation to skin which made soft feeling and smooth feeling compatible.
上記課題を解決した本発明は次記のとおりである。
<請求項1記載の発明>
原紙に対して主成分として、レーザー回析散乱粒度分布による平均粒子径(D50)が3〜15μmのタルクを10〜30重量%、紙用柔軟剤を3〜18重量%、及び保湿成分を60〜80%含むことを特徴とする薬液含有薄葉紙。
The present invention that has solved the above problems is as follows.
<Invention of Claim 1>
As a main component with respect to the base paper, talc having an average particle size (D50) by laser diffraction scattering particle size distribution of 3 to 15 μm is 10 to 30% by weight, softener for paper is 3 to 18% by weight, and moisturizing component is 60%. A medicinal solution-containing thin paper containing -80%.
(作用効果)
本発明においては、保湿成分を含むのでしっとり感を与える。紙用柔軟剤は柔軟効果を与える。本発明においては、タルクを使用している。このタルクは、特許文献3にも示されているように、さらさら感の向上に寄与する。しかるに、本発明においては、特に平均粒径の小さいタルクを使用しているので、さらさら感に基づく滑らか感が特に優れる。
平均粒径が15μmを超えると滑らか感に劣るものとなる。また、紙から離脱する量が多くなり、使用者に不快感を与える傾向がある。また、平均粒径が3μm未満でも、紙から離脱する量が多くなることが知見された。
さらに、タルクを紙用柔軟剤と併用することで、滑らか感のほか柔らか感が向上することが知見された。
(Function and effect)
In the present invention, since it contains a moisturizing component, it gives a moist feeling. Paper softeners provide a softening effect. In the present invention, talc is used. This talc contributes to the improvement of the smooth feeling as shown in Patent Document 3. However, in the present invention, since talc having a small average particle diameter is used, the smooth feeling based on the smooth feeling is particularly excellent.
When the average particle size exceeds 15 μm, the smoothness is inferior. In addition, the amount of separation from the paper increases, which tends to make the user uncomfortable. Further, it has been found that even when the average particle size is less than 3 μm, the amount released from the paper increases.
Furthermore, it has been found that softness is improved in addition to smoothness by using talc together with a paper softener.
<請求項2記載の発明>
保湿成分がグリセリンである請求項1記載の薬液含有薄葉紙。
<Invention of Claim 2>
The medicinal solution-containing thin paper according to claim 1, wherein the moisturizing component is glycerin.
(作用効果)
グリセリンは保湿効果が高い。
(Function and effect)
Glycerin has a high moisturizing effect.
<請求項3記載の発明>
接着成分を含まない請求項1または2記載の薬液含有薄葉紙。
<Invention of Claim 3>
The medicinal solution-containing thin paper according to claim 1 or 2, which does not contain an adhesive component.
(作用効果)
タルクを含有させる場合、タルクを原紙に定着させるために接着成分を用いることができるが、接着成分はタルクの移動を阻害するので、使用時に肌が接触したときタルクにより肌を痛める恐れがある。それだけでなく、接着成分を含有することにより紙が硬くなるため、肌への刺激が増す。これに対して、接着成分を含有しないことにより、タルクが紙に対して強固に接着せず、使用時に添加されたタルクが肌の上を転がる又は滑ることによって肌への刺激を減らすことができる。そして、前述のように、本発明のタルクはレーザー回析散乱粒度分布による平均粒子径(D50)が3〜15μmで、小さいながらも過度に微粉末でないのでタルクの離脱はほとんどなく、肌への転移に伴う不快感を防止できる。レーザー回析式粒度分布測定装置として、島津製作所社製「SALD−2200」を使用して測定したものである。
(Function and effect)
When talc is contained, an adhesive component can be used to fix talc to the base paper. However, since the adhesive component inhibits talc movement, there is a risk of hurting the skin due to talc when the skin comes into contact during use. In addition, since the paper becomes hard by containing an adhesive component, irritation to the skin increases. On the other hand, by not containing an adhesive component, the talc does not adhere firmly to the paper, and the talc added during use can reduce irritation to the skin by rolling or sliding on the skin. . As described above, the talc of the present invention has an average particle diameter (D50) of 3 to 15 μm based on the laser diffraction scattering particle size distribution, and is small but not excessively fine powder, so there is almost no talc detachment, Discomfort associated with metastasis can be prevented. This is measured using “SALD-2200” manufactured by Shimadzu Corporation as a laser diffraction type particle size distribution measuring apparatus.
以上のとおり本発明によれば、柔らか感および滑らか感を両立でき、肌への刺激をより少なくできる等の利点がもたらされる。 As described above, according to the present invention, it is possible to achieve both a soft feeling and a smooth feeling and to bring about advantages such as less irritation to the skin.
以下、本発明の実施形態について詳説する。
本発明の薄葉紙の原紙としては、公知のものを限定無く用いることができるが、特にパルプ原料におけるNBKP配合率(JIS P 8120)が30.0〜80.0%、特に40.0〜70.0%であるものが好適である。米坪(JIS P 8124)は、1プライ当たり10.0〜35.0g/m2が望ましい。紙厚(尾崎製作所製ピーコックにより測定)は2プライ(2枚重ね)で100〜300μm、1プライの場合はその半分であるのが望ましい。クレープ率(((製紙時のドライヤーの周速)−(リール周速))/(製紙時のドライヤーの周速)×100)は15.0〜26.0が望ましい。
Hereinafter, embodiments of the present invention will be described in detail.
As the base paper of the thin paper of the present invention, known ones can be used without limitation, but the NBKP blending ratio (JIS P 8120) in the pulp raw material is 30.0 to 80.0%, particularly 40.0 to 70. What is 0% is suitable. As for the rice tsubo (JIS P 8124), 10.0 to 35.0 g / m 2 per ply is desirable. The paper thickness (measured with a Peacock manufactured by Ozaki Mfg. Co., Ltd.) is desirably 2 plies (two stacked), 100 to 300 μm, and half for one ply. The crepe rate (((peripheral speed of the dryer during paper manufacture) − (reel peripheral speed)) / (peripheral speed of the dryer during paper manufacture) × 100) is desirably 15.0 to 26.0.
本発明の原紙としては、JIS P 8113に規定される乾燥引張強度(以下、乾燥紙力ともいう)が、2プライで縦方向130cN/25mm以上、特に280〜310cN/25mm、横方向40cN/25mm以上、特に60〜100cN/25mmのものを用いるのが好ましく、1プライの場合はその半分であるのが望ましい。原紙の乾燥紙力が低過ぎると、製造時に破れや伸び等のトラブルが発生し易くなり、高過ぎると使用時にごわごわした肌触りとなる。 The base paper of the present invention has a dry tensile strength (hereinafter also referred to as dry paper strength) specified in JIS P 8113 of 2 plies in a longitudinal direction of 130 cN / 25 mm or more, particularly 280 to 310 cN / 25 mm, and a transverse direction of 40 cN / 25 mm. As described above, it is particularly preferable to use one having a thickness of 60 to 100 cN / 25 mm. When the dry paper strength of the base paper is too low, troubles such as tearing and elongation are likely to occur during production, and when it is too high, the touch becomes stiff when used.
これらの紙力は公知の方法により調整でき、例えば、紙力剤を内添(ドライヤーパートよりも前の段階、例えばパルプスラリーに添加)する、パルプのフリーネスを低下(例えば30〜40ml程度低下)させる、NBKP配合率を増加(例えば50%以上に)する等の手法を適宜数組み合わせることができる。 These paper strengths can be adjusted by a known method. For example, a paper strength agent is internally added (added to a stage before the dryer part, for example, pulp slurry), and pulp freeness is reduced (for example, about 30 to 40 ml is reduced). It is possible to appropriately combine several methods such as increasing the NBKP blending ratio (for example, 50% or more).
紙力としては湿潤紙力を確保することが重要であり、この湿潤紙力剤としては、ポリアミド・エピクロルヒドリン樹脂、尿素樹脂、酸コロイド・メラミン樹脂、熱架橋性付与PAM等を用いることができる。湿潤紙力剤を内添する場合、その添加量はパルプスラリーに対する重量比で5〜20kg/t程度とすることができる。 As paper strength, it is important to ensure wet paper strength. As this wet paper strength agent, polyamide / epichlorohydrin resin, urea resin, acid colloid / melamine resin, thermal crosslinkability imparting PAM, or the like can be used. When the wet paper strength agent is internally added, the addition amount can be about 5 to 20 kg / t in weight ratio to the pulp slurry.
本発明では、原紙中に薬液が含有される。薄葉紙における薬液含有量は、原紙に対して5〜35重量%が望ましい。特に好ましい範囲は20〜30重量%である。薬液含有量が少な過ぎると効果が乏しくなるだけでなく、原紙に対する塗布量が安定しなくなり、多過ぎるとべとつくようになり、柔らか感や滑らか感が阻害される。薬液を含有させるための方法としては、スプレー塗布、ロール塗布、浸漬等、公知の付与方法を用いることができる。 In the present invention, a chemical is contained in the base paper. The chemical content in the thin paper is preferably 5 to 35% by weight with respect to the base paper. A particularly preferred range is 20 to 30% by weight. If the chemical content is too small, not only will the effect be poor, but the amount applied to the base paper will not be stable, and if it is too large, it will become sticky and the softness and smoothness will be hindered. As a method for containing the chemical solution, a known application method such as spray coating, roll coating, or immersion can be used.
前記薬液は、60〜100重量%程度、特に80〜95重量%程度の有効成分と、0〜40重量%程度、特に5〜20重量%程度の水分等の非有効成分とで構成することができる。 The chemical solution may be composed of about 60 to 100% by weight, particularly about 80 to 95% by weight of an active ingredient, and about 0 to 40% by weight, especially about 5 to 20% by weight of an ineffective ingredient such as moisture. it can.
本発明では、前記有効成分中の主成分として、レーザー回析散乱粒度分布による平均粒子径(D50)が3〜15μm(特に望ましくは5〜10μm)のタルクを10〜30重量%、紙用柔軟剤を3〜18重量%、及び保湿成分を60〜80%含むものである。 In the present invention, 10 to 30% by weight of talc having an average particle size (D50) of 3 to 15 μm (particularly desirably 5 to 10 μm) as a main component in the active ingredient is 10 to 30% by weight, and is flexible for paper. 3 to 18% by weight of the agent and 60 to 80% of the moisturizing component.
タルクの市販品には、0.5μm〜35μm程度のものがあるが、本発明においては、3〜15μmのタルクが使用される。タルクの粒径が小さ過ぎても滑らか感は担保されるが、紙からの離脱量が多く、またタルクが毛穴に入り肌トラブルの原因となるおそれがある。反対に粒径が15μmを超えて大き過ぎると滑らか感の向上効果が低下する。すなわち、滑らか感はパルプ繊維の隙間にパウダーが入り込み空隙を埋めることで繊維の凹凸の差が少なくなることで発揮するものと考えられるところ、15μmを超えてタルク粒径が大き過ぎると繊維の空隙に入り込むことができないため、滑らか感の向上に寄与しないものと考えられる。 There are commercially available products of talc of about 0.5 μm to 35 μm, but 3 to 15 μm of talc is used in the present invention. Even if the particle size of the talc is too small, a smooth feeling is secured, but the amount of separation from the paper is large, and the talc may enter the pores and cause skin trouble. On the other hand, if the particle size exceeds 15 μm and is too large, the effect of improving smoothness is reduced. In other words, smoothness is considered to be exhibited by the powder entering the gaps between the pulp fibers and filling the gaps, thereby reducing the difference in the irregularities of the fibers. If the talc particle size exceeds 15 μm, the pores of the fibers Since it cannot penetrate, it is thought that it does not contribute to the improvement of smoothness.
タルクに対して、平均粒径がより大きい15超〜40μm(特に20〜30μmが望ましい)の他のパウダー(特に粒状体のものが望ましい)と併用することもできる。併用する他のパウダーとしては、タルクに対し、50重量%未満が望ましい。 It can also be used in combination with other powders (especially those in the form of granules) having an average particle size of more than 15 to 40 μm (especially 20 to 30 μm is desirable) relative to talc. As other powder used together, less than 50 weight% is desirable with respect to talc.
また、タルクは板状結晶であるために、使用した時に肌の上を滑ることにより滑らかな触感を与え、肌への刺激を減らす。澱粉等の粒状体は製品を使用した時に粒子が肌の上を転がることで滑らかな触感となり、肌への刺激を減らす。 In addition, since talc is a plate-like crystal, it gives a smooth tactile sensation by sliding on the skin when used, and reduces irritation to the skin. Granules, such as starch, provide a smooth feel when the product rolls over the skin, reducing skin irritation.
また、タルク及び併用する他のパウダーの配合比に関してタルクが多過ぎ、併用する他のパウダーが少なすぎる場合、滑らか感は向上するが、柔らか感に乏しくなる。反対に、タルクが少な過ぎ、併用する他のパウダーが多過ぎる場合、柔らか感は向上するが、滑らか感に乏しくなる。 Moreover, when there is too much talc regarding the blending ratio of talc and other powders to be used together and there are too few other powders to be used together, the smooth feeling is improved, but the soft feeling is poor. On the other hand, when there is too little talc and too many other powders are used together, the soft feeling is improved, but the smooth feeling is poor.
さらに、薬液中のタルク含有量が多過ぎると、薬液の流動性が低下し、原紙への浸透性・定着性が悪くなる。また、タルク含有量が少な過ぎると、パウダー添加による効果が乏しくなる。 Furthermore, when there is too much talc content in a chemical | medical solution, the fluidity | liquidity of a chemical | medical solution will fall and the permeability and fixing property to a base paper will worsen. Moreover, when there is too little talc content, the effect by powder addition will become scarce.
前記併用可能な他のパウダーとしては、カオリン、クレー、炭酸カルシウム、酸化チタン等の無機物粉体や、金属石鹸(ステアリン酸アルミニウム、ステアリン酸マグネシウム、ステアリン酸カルシウム、ステアリン酸亜鉛、ステアリン酸リチウム等)、コーンスターチ、小麦粉、米デンプン、馬鈴薯澱粉、小麦粉タンパク質等の有機物粉体を単独または複数種組み合わせて用いることができる。このうち、澱粉が最適であり、例示の他のパウダーでは効果が顕著でない。 Other powders that can be used in combination include inorganic powders such as kaolin, clay, calcium carbonate, titanium oxide, and metal soaps (aluminum stearate, magnesium stearate, calcium stearate, zinc stearate, lithium stearate, etc.), Organic powders such as corn starch, wheat flour, rice starch, potato starch, and wheat flour protein can be used singly or in combination. Among these, starch is optimal, and the effect is not remarkable in the other powders exemplified.
薬液中にタルクを含有させる場合、いわゆるローション剤中にタルクを含有させて紙に転写方式によりローション剤共に紙に定着させることができる。 When talc is contained in the chemical, talc can be contained in a so-called lotion agent, and the lotion agent can be fixed on the paper by a transfer method.
本発明において有効成分の主成分として、他に保湿剤を含有させる。保湿剤としては、グリセリン、ジグリセリン、プロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール等の多価アルコール、ソルビトール、グルコース、キシリトール、マルトース、マルチトール、マンニトール、トレハロース等の糖類、グルコール系薬剤およびその誘導体、セタノール(セチルアルコール)、ステアリルアルコール、セトステアリルアルコール、オレイルアルコール等の高級アルコール(高級アルコールの中でも脂肪族アルコールに属するもの)、流動パラフィン、コラーゲン、加水分解コラーゲン、加水分解ケラチン、加水分解シルク、ヒアルロン酸若しくはその塩、セラミド等の1種以上を任意の組合せで用いることができる。保湿剤は、パウダーを除いた主成分中60〜80重量%、特に65〜75重量%含有するのが好ましい。 In the present invention, a moisturizing agent is additionally contained as a main component of the active ingredient. Examples of humectants include polyhydric alcohols such as glycerin, diglycerin, propylene glycol, 1,3-butylene glycol, and polyethylene glycol; sugars such as sorbitol, glucose, xylitol, maltose, maltitol, mannitol, and trehalose; Derivatives, higher alcohols such as cetanol (cetyl alcohol), stearyl alcohol, cetostearyl alcohol, oleyl alcohol (which belongs to aliphatic alcohols among higher alcohols), liquid paraffin, collagen, hydrolyzed collagen, hydrolyzed keratin, hydrolyzed One or more of silk, hyaluronic acid or a salt thereof, ceramide and the like can be used in any combination. The humectant is preferably contained in the main component excluding the powder in an amount of 60 to 80% by weight, particularly 65 to 75% by weight.
保湿剤として、グリセリンを採用して、主成分中60〜80重量%含有させるのが特に望ましい。 It is particularly desirable to employ glycerin as a moisturizing agent and contain 60 to 80% by weight in the main component.
他に有効な保湿剤としては、流動パラフィンがあるが、その量は保湿成分中に10%以下、特に0.5〜5%とするのが望ましい。 Another effective moisturizing agent is liquid paraffin, and the amount is desirably 10% or less, particularly 0.5 to 5% in the moisturizing component.
さらに、保湿剤として、前掲中のうち炭素数14〜24(18〜22がより好ましい)の直鎖又は分岐鎖(直鎖が好ましい)のアルキル基又はアルケニル基を有する脂肪族アルコールが有効である。好ましくは、ミリスチルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコールが挙げられ、また、セチルアルコールとステアリルアルコールの混合物であるセトステアリルアルコールなどの脂肪族アルコールの混合物が挙げられる。特に、セチルアルコール、セトステアリルアルコール、ステアリルアルコールが好ましい。この脂肪族アルコールの添加量としては、保湿成分中に10%以下、特に0.5〜5%とするのが望ましい。 Furthermore, as the humectant, an aliphatic alcohol having a linear or branched (preferably linear) alkyl or alkenyl group having 14 to 24 carbon atoms (preferably 18 to 22) is effective. . Preferred examples include myristyl alcohol, cetyl alcohol, stearyl alcohol, and behenyl alcohol, and mixtures of aliphatic alcohols such as cetostearyl alcohol, which is a mixture of cetyl alcohol and stearyl alcohol. In particular, cetyl alcohol, cetostearyl alcohol, and stearyl alcohol are preferable. The amount of the aliphatic alcohol added is preferably 10% or less, particularly 0.5 to 5% in the moisturizing component.
また、他の有効成分として、薬液中に油性成分、乳化成分、抗カビ成分、消泡成分などを含有させることができる。これらの成分としては、5重量%以下が望ましい。特に油性成分が多過ぎるとべたつき感が増し、乳化成分が多過ぎると泡立ち易くなるため、風合いの悪化や操業性の悪化という問題がある。 Further, as other active ingredients, an oily component, an emulsifying component, an antifungal component, an antifoaming component and the like can be contained in the chemical solution. These components are preferably 5% by weight or less. In particular, when there are too many oil components, the sticky feeling increases, and when there are too many emulsified components, foaming tends to occur, so that there is a problem of deterioration in texture and operability.
油性成分としては、ワセリン等の石油若しくは鉱物油由来成分、ミンク油やラノリン油、スクワラン等の動物油由来成分、オリーブ油、ホホバ油、ローズヒップ油、アーモンド油、ユーカリ油、アボカド油、ツバキ油、大豆油、サフラワー油、ゴマ油、月見草油、ひまわり油等の植物由来成分、アルキルメチルシリコーン等のシリコーン油、流動パラフィンを用いることができる。特に流動パラフィンは好適である。 Oily components include petroleum or mineral oil-derived components such as petrolatum, animal oil-derived components such as mink oil, lanolin oil, squalane, olive oil, jojoba oil, rosehip oil, almond oil, eucalyptus oil, avocado oil, camellia oil, large oil Plant-derived components such as bean oil, safflower oil, sesame oil, evening primrose oil, sunflower oil, silicone oil such as alkylmethyl silicone, and liquid paraffin can be used. Liquid paraffin is particularly suitable.
さて、本発明においては紙用柔軟剤を使用する。紙用柔軟剤としては、有効成分中の主成分中に3〜18重量%使用するのが望ましい。 In the present invention, a paper softener is used. As the paper softener, it is desirable to use 3 to 18% by weight in the main component in the active ingredient.
この紙用柔軟剤としては、アニオン系界面活性剤、非イオン系界面活性剤、カチオン系界面活性剤および両性イオン界面活性剤のなかから適宜選択して用いることができる。また、これらは消泡効果を示しエマルジョン安定性の点にも寄与する。 As the paper softener, an anionic surfactant, a nonionic surfactant, a cationic surfactant and an amphoteric surfactant can be appropriately selected and used. They also exhibit an antifoaming effect and contribute to emulsion stability.
アニオン系界面活性剤としては、カルボン酸塩系、スルホン酸塩系、硫酸エステル塩系、燐酸エステル塩系などを用いることができる。特にアルキル燐酸エステル塩が好ましい。 As the anionic surfactant, carboxylate, sulfonate, sulfate ester, phosphate ester, and the like can be used. An alkyl phosphate ester salt is particularly preferable.
非イオン界面活性剤としては、ソルビタン脂肪酸エステル、ジエチレングリコールモノステアレート、ジエチレングリコールモノオレエート、グリセリルモノステアレート、グリセリルモノオレート、プロピレングリコールモノステアレートなどの多価アルコールモノ脂肪酸エステル、N−(3−オレイロシキ−2−ヒドロキシプロピル)ジエタノールアミン、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビット密ロウ、ポリオキシエチレンソルビタンセスキステアレート、ポリオキシエチレンモノオレエート、ポリオキシエチレンモノラウレート、ポリオキシエチレンセチルエーテル、ポリオキシエチレンラウリルエーテルなどを用いることができる。 Examples of nonionic surfactants include sorbitan fatty acid esters, diethylene glycol monostearate, diethylene glycol monooleate, glyceryl monostearate, glyceryl monooleate, and polyhydric alcohol monofatty acid esters such as N- (3- Oleiroshiki-2-hydroxypropyl) diethanolamine, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan beeswax, polyoxyethylene sorbitan sesquistearate, polyoxyethylene monooleate, polyoxyethylene monolaurate, polyoxyethylene cetyl ether Polyoxyethylene lauryl ether can be used.
カチオン界面活性剤としては、第4級アンモニウム塩、アミン塩、またはアミンなどをもちいることができる。 As the cationic surfactant, a quaternary ammonium salt, an amine salt, an amine, or the like can be used.
また、両性イオン界面活性剤としては、カルボキシ、スルホネート、サルフェートを含有する第2級または第3級アミンの脂肪族誘導体、または複素環式第2級または第3級アミンの脂肪族誘導体などを用いることができる。 In addition, as the zwitterionic surfactant, an aliphatic derivative of a secondary or tertiary amine containing carboxy, sulfonate, sulfate, an aliphatic derivative of a heterocyclic secondary or tertiary amine, or the like is used. be able to.
前掲のなかで、柔軟効果が高いのはカチオン系界面活性剤である。特に第4級アンモニウム塩、とりわけ、下記一般式(A)で表される化合物(成分(A))が最適である。
(式中、R1は、炭素数6〜24の直鎖もしくは分岐鎖のアルキル基もしくはアルケニル基又はR3−O−R4−を示し、R2は、炭素数1〜6の直鎖もしくは分岐鎖のアルキル基又は炭素数1〜3のヒドロキシアルキル基を示し、それぞれ異なっていても良い。R3は炭素数6〜24の直鎖もしくは分岐鎖のアルキル基もしくはアルケニル基、R4は炭素数1〜6の直鎖のアルキレン基を示す。X-は陰イオンを示す。)
Among the foregoing, cationic surfactants have a high softening effect. In particular, a quaternary ammonium salt, particularly a compound represented by the following general formula (A) (component (A)) is optimal.
(In the formula, R 1 represents a linear or branched alkyl group or alkenyl group having 6 to 24 carbon atoms or R 3 —O—R 4 —, and R 2 represents a straight chain having 1 to 6 carbon atoms or A branched alkyl group or a hydroxyalkyl group having 1 to 3 carbon atoms, which may be different from each other, R 3 is a linear or branched alkyl group or alkenyl group having 6 to 24 carbon atoms, and R 4 is carbon. Represents a linear alkylene group of 1 to 6. X − represents an anion.)
成分(A)において、R1及びR2は以下に示すものが紙の柔らかさの観点から好ましい。
上記一般式(A)において、R1としては、炭素数6〜24であり、12〜24が好ましく、16〜22がより好ましく、20〜22がさらに好ましい。また、R1は、直鎖もしくは分岐鎖のアルキル基もしくはアルケニル基又はR3−O−R4−であり、R1、R3は直鎖が好ましく、またアルキル基が好ましく、直鎖のアルキル基が特に好ましい。R2は、炭素数1〜6、好ましくは1〜3の直鎖又は分岐鎖のアルキル基若しくは炭素数1〜3のヒドロキシアルキル基であり、それぞれ異なっていても良い。R2は直鎖のアルキル基が好ましい。R4は炭素数1〜6の直鎖のアルキレン基であり、炭素数2〜4が好ましい。
In the component (A), R 1 and R 2 are preferably shown below from the viewpoint of paper softness.
In the above Formula (A), the R 1, a 6 to 24 carbon atoms, preferably from 12 to 24, more preferably from 16 to 22, more preferably 20 to 22. R 1 is a linear or branched alkyl group or alkenyl group or R 3 —O—R 4 —, and R 1 and R 3 are preferably linear, and are preferably alkyl groups. The group is particularly preferred. R 2 is a linear or branched alkyl group having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms, or a hydroxyalkyl group having 1 to 3 carbon atoms, and may be different from each other. R 2 is preferably a linear alkyl group. R 4 is a linear alkylene group having 1 to 6 carbon atoms, preferably 2 to 4 carbon atoms.
X-としては、陰イオンであり、ハロゲンイオン、例えばフッ素イオン、塩素イオン、臭素イオン又はヨウ素イオン、又は有機アニオン、例えば酢酸イオン、クエン酸イオン、乳酸イオン、グリコレート、リン酸イオン、硝酸イオン、スルホン酸イオン、硫酸イオン、並びにメチル硫酸イオン及びエチル硫酸イオン等のアルキル硫酸イオン等が挙げられ、ハロゲンイオン又はアルキル硫酸イオンが好ましく、特に塩素イオン、メチル硫酸イオン又はエチル硫酸イオンが好ましい。 X − is an anion, a halogen ion such as fluorine ion, chlorine ion, bromine ion or iodine ion, or an organic anion such as acetate ion, citrate ion, lactate ion, glycolate, phosphate ion or nitrate ion. Sulphonate ions, sulfate ions, and alkyl sulfate ions such as methyl sulfate ions and ethyl sulfate ions. Halogen ions or alkyl sulfate ions are preferable, and chlorine ions, methyl sulfate ions, or ethyl sulfate ions are particularly preferable.
一般式(A)の化合物として、モノアルキルトリメチルアンモニウム塩、N−アルキル−N,N−ジヒドロキシエチル−N−メチルアンモニウム塩、モノアルキルトリエチルアンモニウム塩、モノアルケニルトリメチルアンモニウム塩、塩化炭化水素オキシアルキレントリメチルアンモニウム塩、などが挙げられる。具体的には、臭化ドデシルトリメチルアンモニウム、臭化ヘキサデシルトリメチルアンモニウムなどの臭化モノアルキルトリメチルアンモニウム、塩化ドデシルトリメチルアンモニウム、塩化水素添加牛脂アルキルトリメチルアンモニウム、塩化硬化パーム油アルキルトリメチルアンモニウム、塩化セチルトリメチルアンモニウム、塩化ステアリルトリメチルアンモニウム、塩化ベヘニルトリメチルアンモニウム、等の塩化モノアルキルトリメチルアンモニウム、エチル硫酸べヘニルトリメチルアンモニウム等のエチル硫酸モノアルキルトリメチルアンモニウムなどが挙げられる。また、塩化オレイルトリメチルアンモニウム等の塩化モノアルケニルトリメチルアンモニウム、塩化オクタデシロキシプロピルトリメチルアンモニウムクロライド等の塩化炭化水素オキシアルキレントリメチルアンモニウムなどが挙げられる(ここでの「炭化水素オキシアルキレン」は、基「R3−O−R4−」を意味する。)。 As a compound of the general formula (A), monoalkyltrimethylammonium salt, N-alkyl-N, N-dihydroxyethyl-N-methylammonium salt, monoalkyltriethylammonium salt, monoalkenyltrimethylammonium salt, oxyhydroalkylenetrimethyl chloride And ammonium salts. Specifically, monoalkyltrimethylammonium bromide such as dodecyltrimethylammonium bromide and hexadecyltrimethylammonium bromide, dodecyltrimethylammonium chloride, hydrogenated beef tallow alkyltrimethylammonium chloride, chlorinated hardened palm oil alkyltrimethylammonium chloride, cetyltrimethyl chloride Examples thereof include monoalkyltrimethylammonium chloride such as ammonium, stearyltrimethylammonium chloride, and behenyltrimethylammonium chloride, and monoalkyltrimethylammonium sulfate such as ethyl behenyltrimethylammonium sulfate. In addition, monoalkenyltrimethylammonium chloride such as oleyltrimethylammonium chloride, hydrocarbon oxyalkylenetrimethylammonium chloride such as octadecyloxypropyltrimethylammonium chloride, and the like (here, “hydrocarbonoxyalkylene” refers to the group “R 3 -O-R 4 - means ")..
上記成分(A)と、前記脂肪族アルコール(成分(B))とを併用すると、成分(A)の柔軟効果がより高まることが知見されている。 It has been found that when the component (A) and the aliphatic alcohol (component (B)) are used in combination, the flexibility effect of the component (A) is further increased.
さらに別の有効成分としては、柔軟剤、ビタミンC、ビタミンE等の各種ビタミン、グリシン、アスパラギン酸、アルギニン、アラニン、シスチン、システィンなどのアミノ酸、アロエエキス、アマチャエキス、アシタバエキス、カリンエキス、キュウリエキス、スギナエキス、トマトエキス、ノバラエキス、ヘチマエキス、ユリエキス、レンゲソウエキスなどの植物抽出エキス、キトサン、尿素、ハチミツ、ローヤルゼリー等を用いることができる。各種ビタミンや植物抽出エキス等の成分は、有効成分中0.000001〜0.001重量%含有されているのが好ましい。 Further active ingredients include softeners, various vitamins such as vitamin C and vitamin E, amino acids such as glycine, aspartic acid, arginine, alanine, cystine, cystine, aloe extract, amacha extract, ashitaba extract, karin extract, cucumber extract Plant extract extracts such as extract, horsetail extract, tomato extract, wild rose extract, loofah extract, lily extract, and spinach extract, chitosan, urea, honey, royal jelly and the like can be used. Components such as various vitamins and plant extracts are preferably contained in the active ingredient in an amount of 0.000001 to 0.001% by weight.
また、メントール、カンファー、シクロヘキサノールなどの昇華成分を有効成分中に3%以下の割合で添加することができる。 Further, sublimation components such as menthol, camphor, and cyclohexanol can be added to the active component at a ratio of 3% or less.
他方、本発明の薄葉紙は製造方法によって限定されるものではないが、折り畳んで積層する製品形態、例えば箱詰め型のティシューペーパーの場合、抄造した原紙に薬液を付与した後、インターフォルダ等の折り畳み装置で折り畳むよりも、折り畳み装置内で折り畳みのために原紙を搬送する過程で薬液を付与するようにすると、効率良く製造でき、また薬液や水分の蒸発も少なく、品質の安定した製品を製造できるようになるため好ましい。なお、後者の方法としては、本出願人による特願2004−251874号を例示することができる。 On the other hand, the thin paper of the present invention is not limited by the manufacturing method. However, in the case of a product form to be folded and stacked, for example, in case of a box-type tissue paper, a folding device such as an interfolder is provided after applying a chemical solution to the produced base paper. Rather than folding in the folding device, the chemical solution is applied in the process of transporting the base paper for folding in the folding device, so that it can be manufactured efficiently and the chemical solution and moisture are less evaporated so that a product with stable quality can be manufactured. This is preferable. An example of the latter method is Japanese Patent Application No. 2004-251874 filed by the present applicant.
いずれにしても、上述の成分は内添、外添あるいは転写などの方法によって原紙に含有させることができる。 In any case, the above-mentioned components can be contained in the base paper by a method such as internal addition, external addition or transfer.
表1〜表4に示す各種の2プライティシューペーパー(実施例1〜15および比較例1〜8)を製造し、各種物性の測定・算出および官能評価を行った。
使用した薬液原液は、パウダーを除いた有効成分92重量%及び水分8%からなり、有効成分中に、表中に記した保湿剤及び柔軟剤のほか、抗酸化剤1重量%及び乳化成分1.0重量%を含むものであった。
また、使用したパウダーは、タルク(竹岡化学社製「TT」平均粒径:7μm、粒子形状:板状)、コーンスターチ(平均粒径:20μm、粒子形状:球状)の二種類であった。
さらに、使用した原紙は、米坪(1プライ)が19g/m2、NBKP配合率が50%、パルプフリーネスが650ml、内添紙力剤の使用量(対パルプスラリー)が15kg/t、縦方向乾燥紙力が298cN/25mm、横方向乾燥紙力が70cN/25mm、縦方向湿潤紙力が169cN/25mm、横方向湿潤紙力が50cN/25mmであった。
なお、物性の測定は、水分率を除いてJIS P 8111に規定される条件下で行った。柔らかさ感の官能評価については、被験者30名により、紙の表面を手で触った際の柔らか感について5点満点(5点:柔らかい、4点:やや柔らかい、3点:柔らかさをあまり感じない、2点:やや硬い、1点:硬い)で点数をつけ、平均点を評価値とした。また、滑らかさの官能評価については、被験者30名により、紙の表面を手で触った際の滑らか感について5点満点(5点:滑らかさを感じる、4点:やや滑らかさを感じる、3点:滑らかをあまり感じない、2点:ややざらざらしている、1点:ざらざらしている)で点数をつけ、平均点を評価値とした。摩擦係数の平均偏差MMDは、カトーテック株式会社製「摩擦感テスター KESSE」を用いて測定した。MMD値が大きいほど滑らかさに劣る又はざらざらしていることを意味する。ソフトネスは、JIS L1096 E法に準じたハンドルオメータ法に基づいて測定した。
Various two-ply shoe papers (Examples 1 to 15 and Comparative Examples 1 to 8) shown in Tables 1 to 4 were produced, and various physical properties were measured and calculated, and sensory evaluation was performed.
The chemical stock solution used was composed of 92% by weight of the active ingredient excluding the powder and 8% of the water content. It contained 0.0% by weight.
Moreover, the used powder was two types, talc (Takeoka Chemical Co., Ltd. “TT” average particle size: 7 μm, particle shape: plate shape) and corn starch (average particle size: 20 μm, particle shape: spherical).
Furthermore, the base paper used was 19 g / m 2 in US basis weight (1 ply), 50% NBKP content, 650 ml of pulp freeness, 15 kg / t of internal paper strength agent (vs. pulp slurry), vertical The directional dry paper force was 298 cN / 25 mm, the horizontal dry paper force was 70 cN / 25 mm, the vertical wet paper force was 169 cN / 25 mm, and the horizontal wet paper force was 50 cN / 25 mm.
The physical properties were measured under the conditions defined in JIS P 8111 except for the moisture content. Regarding the sensory evaluation of the soft feeling, 30 subjects gave a soft feeling when touching the surface of the paper with 30 hands (5 points: soft, 4 points: slightly soft, 3 points: soft feeling too much No score, 2 points: slightly hard, 1 point: hard), and the average score was taken as the evaluation value. In addition, for sensory evaluation of smoothness, 30 subjects gave a smooth feel when touching the surface of paper with 30 hands (5 points: feel smoothness, 4 points: feel somewhat smoothness) 3 The points were scored with 2 points: slightly rough, 1 point: rough, and the average score was used as the evaluation value. The average deviation MMD of the friction coefficient was measured using “Friction Tester KESSE” manufactured by Kato Tech Co., Ltd. The larger the MMD value, the less smooth or rough it is. The softness was measured based on the handle ohm method according to JIS L1096 E method.
表1からも判るように、本発明に係る実施例1〜4は、比較例1〜9と異なり、柔らか感、滑らか感が両立するという結果が得られた。 As can be seen from Table 1, Examples 1 to 4 according to the present invention differed from Comparative Examples 1 to 9 in that both softness and smoothness were achieved.
本発明は、ティシューペーパー、トイレットペーパー、キッチンペーパー、クレープ紙等の薄葉紙に適用可能なものである。 The present invention is applicable to thin paper such as tissue paper, toilet paper, kitchen paper, and crepe paper.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006266135A JP5427339B2 (en) | 2006-09-28 | 2006-09-28 | Chemical tissue-containing tissue paper |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006266135A JP5427339B2 (en) | 2006-09-28 | 2006-09-28 | Chemical tissue-containing tissue paper |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008080027A true JP2008080027A (en) | 2008-04-10 |
JP5427339B2 JP5427339B2 (en) | 2014-02-26 |
Family
ID=39351464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006266135A Expired - Fee Related JP5427339B2 (en) | 2006-09-28 | 2006-09-28 | Chemical tissue-containing tissue paper |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5427339B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011156120A (en) * | 2010-01-29 | 2011-08-18 | Daio Paper Corp | Tissue and method of manufacturing tissue |
JP2015188659A (en) * | 2014-03-28 | 2015-11-02 | 王子ホールディングス株式会社 | Wet sheet and package thereof |
JP6393821B1 (en) * | 2017-11-30 | 2018-09-19 | ミヨシ油脂株式会社 | Paper processing agent |
JP7036307B1 (en) | 2021-10-22 | 2022-03-15 | 河野製紙株式会社 | Textile web products and their manufacturing methods |
JP7090858B1 (en) | 2021-10-22 | 2022-06-27 | 河野製紙株式会社 | Textile web products and their manufacturing methods |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07145596A (en) * | 1993-11-18 | 1995-06-06 | Toray Dow Corning Silicone Co Ltd | Composition for treating wiping paper |
JPH07216786A (en) * | 1994-01-27 | 1995-08-15 | Daio Paper Corp | Soft fibrous web and production thereof |
JPH10226986A (en) * | 1997-02-13 | 1998-08-25 | Kouno Seishi Kk | Paper product and its production |
JP2001011790A (en) * | 1999-06-28 | 2001-01-16 | Kouno Seishi Kk | Fiber web product and its production |
JP2002330820A (en) * | 2001-05-11 | 2002-11-19 | Daio Paper Corp | Skin cleaning-wiping tissue paper |
JP2005237745A (en) * | 2004-02-27 | 2005-09-08 | Crecia Corp | Tissue paper |
JP2006118089A (en) * | 2004-10-21 | 2006-05-11 | Lion Corp | Tissue paper-treating agent and tissue paper |
JP2008006273A (en) * | 2006-06-02 | 2008-01-17 | Lion Corp | Tissue paper |
-
2006
- 2006-09-28 JP JP2006266135A patent/JP5427339B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07145596A (en) * | 1993-11-18 | 1995-06-06 | Toray Dow Corning Silicone Co Ltd | Composition for treating wiping paper |
JPH07216786A (en) * | 1994-01-27 | 1995-08-15 | Daio Paper Corp | Soft fibrous web and production thereof |
JPH10226986A (en) * | 1997-02-13 | 1998-08-25 | Kouno Seishi Kk | Paper product and its production |
JP2001011790A (en) * | 1999-06-28 | 2001-01-16 | Kouno Seishi Kk | Fiber web product and its production |
JP2002330820A (en) * | 2001-05-11 | 2002-11-19 | Daio Paper Corp | Skin cleaning-wiping tissue paper |
JP2005237745A (en) * | 2004-02-27 | 2005-09-08 | Crecia Corp | Tissue paper |
JP2006118089A (en) * | 2004-10-21 | 2006-05-11 | Lion Corp | Tissue paper-treating agent and tissue paper |
JP2008006273A (en) * | 2006-06-02 | 2008-01-17 | Lion Corp | Tissue paper |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011156120A (en) * | 2010-01-29 | 2011-08-18 | Daio Paper Corp | Tissue and method of manufacturing tissue |
JP2015188659A (en) * | 2014-03-28 | 2015-11-02 | 王子ホールディングス株式会社 | Wet sheet and package thereof |
JP6393821B1 (en) * | 2017-11-30 | 2018-09-19 | ミヨシ油脂株式会社 | Paper processing agent |
JP2019099938A (en) * | 2017-11-30 | 2019-06-24 | ミヨシ油脂株式会社 | Paper treating agent |
JP7036307B1 (en) | 2021-10-22 | 2022-03-15 | 河野製紙株式会社 | Textile web products and their manufacturing methods |
JP7090858B1 (en) | 2021-10-22 | 2022-06-27 | 河野製紙株式会社 | Textile web products and their manufacturing methods |
WO2023067846A1 (en) | 2021-10-22 | 2023-04-27 | 河野製紙株式会社 | Fiber web product and production method therefor |
JP2023062954A (en) * | 2021-10-22 | 2023-05-09 | 河野製紙株式会社 | Fiber web product and production method therefor |
JP2023063206A (en) * | 2021-10-22 | 2023-05-09 | 河野製紙株式会社 | Fiber web product and production method therefor |
Also Published As
Publication number | Publication date |
---|---|
JP5427339B2 (en) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4287438B2 (en) | Thin paper containing chemicals | |
JP4916832B2 (en) | Sanitary paper | |
TW397879B (en) | Wet-like cleaning wipes and like articles comprising a carrier substrate treated with high internal water phase inverse emulsion | |
JP2007204868A5 (en) | ||
JP4833936B2 (en) | Tissue paper | |
JP5427339B2 (en) | Chemical tissue-containing tissue paper | |
JP2008006273A (en) | Tissue paper | |
JP6105877B2 (en) | Sanitary tissue paper | |
JP3950461B2 (en) | Sanitary paper | |
JP5363698B2 (en) | Chemical tissue-containing tissue paper | |
WO2019106985A1 (en) | Paper treatment agent | |
JP2007100229A5 (en) | ||
JP3682257B2 (en) | Sanitary paper | |
JP6556282B1 (en) | Paper processing agent | |
JP4753544B2 (en) | Tissue paper and tissue paper manufacturing method | |
JP2008080028A (en) | Sanitary paper | |
JP2007204869A (en) | Chemical-containing tissue paper | |
JP2005287578A5 (en) | ||
JP6747966B2 (en) | Method for producing paper treating agent and method for improving texture of paper | |
JP4658099B2 (en) | Tissue paper | |
JP6684135B2 (en) | Sanitary thin paper manufacturing apparatus and sanitary thin paper manufacturing method | |
JP6773875B2 (en) | Method of manufacturing paper treatment agent and method of improving the texture of paper | |
JP2001252214A (en) | Thin light paper and production method therefor | |
JP6900562B2 (en) | Method of manufacturing paper treatment agent and method of improving the texture of paper | |
JP6198221B2 (en) | Surface-coated crepe paper and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090907 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110616 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110822 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120420 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120619 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130201 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130402 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131122 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131202 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5427339 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |